Vise Technologies’s Apellis Pharmaceuticals APLS Stock Holding History

Vise Technologies’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,012	Closed	-$226K	–	1816
2026 Q1	$226K	Hold	9,012	–	–	﹤0.01%	1316
2025 Q4	$226K	Buy	+9,012	New	+$211K	﹤0.01%	1326

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vise Technologies's APLS Position: Q2 2026 in Review

Vise Technologies sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 9,012 shares — an estimated $226K sold.

Vise Technologies first reported a position in APLS in Q4 2025 and held it in 2 quarters. The position peaked at $226K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Vise Technologies reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Vise Technologies sold 9,012 Apellis Pharmaceuticals shares in Q2 2026, an estimated $226K.
Vise Technologies first reported a position in Apellis Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Vise Technologies's Apellis Pharmaceuticals position peaked at $226K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.